<DOC>
	<DOCNO>NCT02118519</DOCNO>
	<brief_summary>Induction autologous repair chondrogenesis regenerate injure articular cartilage use bone marrow mesenchymal stem cell ( MSCs ) vitro expansion restrict culturing condition .</brief_summary>
	<brief_title>Mesenchymal Stem Cells Knee Cartilage Injuries</brief_title>
	<detailed_description>Fourteen patient gender , age range 40-68 , enrol accord strict inclusion exclusion criterion , divide two equal group base upon receive autologous MSCs alone , MSCs support platelet lysate percutaneous injection . The patient follow clinical assessment , laboratory investigation well magnetic resonance imaging ( MRI ) inject knee . The investigator hypothesize two group give satisfactory clinical outcome , investigator look forward assess best product activate chondrogenesis heal cartilaginous injury .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>MRI must show moderate/severe articular injury Serum collagen II must normal value . Lesion site : Femoral Tibial condyle patella Admission steroid , NSAID , pain killer must stop 1 month Lesion size PT PTT within normal value Complete blood count ( Hb , PCV , RBC ) within normal value HIV Hepatitis Antigens ( B C ) detection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Bone marrow derive Mesenchymal Stem Cells</keyword>
	<keyword>Knee articular cartilage injury</keyword>
	<keyword>Chondrogenesis</keyword>
	<keyword>orthopedics</keyword>
</DOC>